Cassava Sciences Inc (NASDAQ: SAVA) is 14.41% higher on its value in year-to-date trading and has touched a low of $2.23 and a high of $42.20 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SAVA stock was last observed hovering at around $2.78 in the last trading session, with the day’s loss setting it -0.08%.
Currently trading at $2.70, the stock is 11.23% and 4.81% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.37 million and changing -2.88% at the moment leaves the stock -84.52% off its SMA200. SAVA registered -88.63% loss for a year compared to 6-month loss of -91.14%.
The stock witnessed a 3.05% gain in the last 1 month and extending the period to 3 months gives it a -89.97%, and is 15.88% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.13% over the week and 5.30% over the month.
Cassava Sciences Inc (SAVA) has around 29 employees, a market worth around $129.90M and $0.00M in sales. Distance from 52-week low is 21.08% and -93.60% from its 52-week high. The company has generated returns on investments over the last 12 months (-10.60%).
The EPS is expected to grow by 62.79% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
The shares outstanding are 47.98M, and float is at 41.80M with Short Float at 37.93%.
The top institutional shareholder in the company is GALLACHER CAPITAL MANAGEMENT LLC with over 0.58 million shares valued at $7.19 million. The investor’s holdings represent 8.8252 of the SAVA Shares outstanding. As of 2024-06-30, the second largest holder is LMR PARTNERS LLP with 0.54 million shares valued at $6.62 million to account for 8.1178 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 3.22 million shares representing 7.4874 and valued at over $39.76 million, while VANGUARD GROUP INC holds 6.2397 of the shares totaling 2.68 million with a market value of $33.14 million.
Cassava Sciences Inc (SAVA) Insider Activity
The most recent transaction is an insider sale by Kupiec James William, the company’s Chief Medical Officer. SEC filings show that Kupiec James William sold 4,000 shares of the company’s common stock on Nov 29 ’24 at a price of $3.87 per share for a total of $15480.0. Following the sale, the insider now owns 0.0 shares.
Cassava Sciences Inc disclosed in a document filed with the SEC on Nov 29 ’24 that Schoen Eric (Chief Financial Officer) sold a total of 59,800 shares of the company’s common stock. The trade occurred on Nov 29 ’24 and was made at $3.86 per share for $0.23 million. Following the transaction, the insider now directly holds 11500.0 shares of the SAVA stock.
Still, SEC filings show that on Nov 29 ’24, Schoen Eric (Chief Financial Officer) disposed off 2,000 shares at an average price of $3.82 for $7640.0. The insider now directly holds 0 shares of Cassava Sciences Inc (SAVA).
